Pesquisar
Novartis AG
NVSAdicionar à lista de desejos
159.870USD
+5.730+3.72%
Fechamento 07/02, 13:00（ET）Cotações atrasadas em 15 min
305.05BValor de mercado
22.75P/L TTM
Mais detalhes de Novartis AG Empresa
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.
Informações de Novartis AG
Código da empresaNVS
Nome da EmpresaNovartis AG
Data de listagemMay 07, 2001
CEONarasimhan (Vasant)
Número de funcionários75883
Tipo de títulosDepository Receipt
Fim do ano fiscalMay 07
EndereçoLichtstrasse 35
CidadeBASEL
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísSwitzerland
Código postal4056
Telefone41613241111
Sitehttps://www.novartis.com/
Código da empresaNVS
Data de listagemMay 07, 2001
CEONarasimhan (Vasant)
Executivos da empresa Novartis AG
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Harry Kirsch
Mr. Harry Kirsch
Chief Financial Officer, Member of the Executive Committee
Chief Financial Officer, Member of the Executive Committee
--
--
Ms. Charlotte Pamer- Wieser, Ph.D.
Ms. Charlotte Pamer- Wieser, Ph.D.
Corporate Secretary
Corporate Secretary
--
--
Dr. Nancy C. Andrews, M.D., Ph.D.
Dr. Nancy C. Andrews, M.D., Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Ton Buechner
Mr. Ton Buechner
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Elizabeth (Liz) Doherty
Ms. Elizabeth (Liz) Doherty
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Vasant (Vas) Narasimhan, M.D.
Dr. Vasant (Vas) Narasimhan, M.D.
Chief Executive Officer, Member of the Executive Committee
Chief Executive Officer, Member of the Executive Committee
--
--
Mr. Frans van Houten
Mr. Frans van Houten
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Steffen Lang, Ph.D.
Dr. Steffen Lang, Ph.D.
President - Operations, Member of the Executive Committee
President - Operations, Member of the Executive Committee
--
--
Mr. Patrice Bula
Mr. Patrice Bula
Non-Executive Lead Independent Director
Non-Executive Lead Independent Director
--
--
Ms. Bridgette P. Heller
Ms. Bridgette P. Heller
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Harry Kirsch
Mr. Harry Kirsch
Chief Financial Officer, Member of the Executive Committee
Chief Financial Officer, Member of the Executive Committee
--
--
Ms. Charlotte Pamer- Wieser, Ph.D.
Ms. Charlotte Pamer- Wieser, Ph.D.
Corporate Secretary
Corporate Secretary
--
--
Dr. Nancy C. Andrews, M.D., Ph.D.
Dr. Nancy C. Andrews, M.D., Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Ton Buechner
Mr. Ton Buechner
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Elizabeth (Liz) Doherty
Ms. Elizabeth (Liz) Doherty
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Vasant (Vas) Narasimhan, M.D.
Dr. Vasant (Vas) Narasimhan, M.D.
Chief Executive Officer, Member of the Executive Committee
Chief Executive Officer, Member of the Executive Committee
--
--
Perguntas frequentes
Quem são os cinco principais acionistas de Novartis AG?
Os cinco principais acionistas de Novartis AG são: Mr. Harry Kirsch
Quantas instituições possuem ações da Novartis AG (NVS)?
Em 2026Q1, 2164 instituições possuíam ações da Novartis AG, com valor de mercado aproximado de 143.01M, representando 7.49% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -1630148.00.
Qual é a maior fonte de receita da Novartis AG?
Em 2026Q1, o segmento de negócios Rest of portfolio gerou a maior receita para Novartis AG, totalizando 10.02B e representando 18.37% da receita total.